A novel CK isoenzyme migrating between CK-MB and CK-BB

Area of Science:

• Biochemistry
• Oncology
• Clinical Chemistry

Background:

• Creatine kinase (CK) isoenzymes are crucial biomarkers in clinical diagnostics.
• CK-BB is typically associated with the central nervous system, while CK-MB is specific to cardiac muscle.
• Prostatic carcinoma, a significant malignancy, warrants further investigation into its biochemical markers.

Purpose of the Study:

• To identify and characterize an atypical CK isoenzyme detected in patients with metastatic prostatic carcinoma.
• To investigate the presence of other CK isoenzymes, including CK-BB and mitochondrial CK, in these patients.
• To determine the clinical significance of the observed CK isoenzyme profile.

Main Methods:

• Serum samples from three patients with metastatic prostatic carcinoma were analyzed.
• Electrophoretic separation was used to detect and characterize CK isoenzymes.
• Immunological assays and other biochemical tests were performed to rule out known isoenzymes and interfering substances.

Main Results:

• An atypical CK isoenzyme migrating between CK-MB and CK-BB was consistently detected.
• CK-BB and mitochondrial CK were also found in the patients' serum.
• The atypical isoenzyme was confirmed not to be CK-MB, an albumin-ligand complex, adenylate kinase, or immunoglobulin-bound.
• The isoenzyme contained some CK-B subunits and lacked normal CK-M subunits, suggesting a variant CK-BB or CK-MB form.

Conclusions:

• The presence of an atypical CK isoenzyme, alongside CK-BB and mitochondrial CK, in patients with metastatic prostatic carcinoma is a significant finding.
• This unique CK isoenzyme profile may serve as a potential indicator of advanced or serious illness in prostate cancer.
• Further research is warranted to elucidate the exact nature and diagnostic utility of this variant CK isoenzyme.